Correlation Between Adaptimmune Therapeutics and Cabaletta Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Cabaletta Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Cabaletta Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Cabaletta Bio, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Cabaletta Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Cabaletta Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Cabaletta Bio.

Diversification Opportunities for Adaptimmune Therapeutics and Cabaletta Bio

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Adaptimmune and Cabaletta is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Cabaletta Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabaletta Bio and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Cabaletta Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabaletta Bio has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Cabaletta Bio go up and down completely randomly.

Pair Corralation between Adaptimmune Therapeutics and Cabaletta Bio

Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 0.54 times more return on investment than Cabaletta Bio. However, Adaptimmune Therapeutics Plc is 1.85 times less risky than Cabaletta Bio. It trades about -0.07 of its potential returns per unit of risk. Cabaletta Bio is currently generating about -0.04 per unit of risk. If you would invest  80.00  in Adaptimmune Therapeutics Plc on November 1, 2024 and sell it today you would lose (19.00) from holding Adaptimmune Therapeutics Plc or give up 23.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Adaptimmune Therapeutics Plc  vs.  Cabaletta Bio

 Performance 
       Timeline  
Adaptimmune Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adaptimmune Therapeutics Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Cabaletta Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cabaletta Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Adaptimmune Therapeutics and Cabaletta Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adaptimmune Therapeutics and Cabaletta Bio

The main advantage of trading using opposite Adaptimmune Therapeutics and Cabaletta Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Cabaletta Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabaletta Bio will offset losses from the drop in Cabaletta Bio's long position.
The idea behind Adaptimmune Therapeutics Plc and Cabaletta Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.